WASHINGTON--(BUSINESS WIRE)--As the House of Representatives’ Committee on Energy and Commerce holds a hearing today on follow-on biologics, the Biotechnology Industry Organization (BIO) issued a statement of facts in response to misleading public statements on follow-on biologics made by the Generic Pharmaceutical Association (GPhA) and others.
